PubMed COVID-19 Clinical Care
11501 - 11510 of 57354 results found
Tocilizumab treatment in MOGAD: a case report and literature review
Description
Myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease (MOGAD) is an autoimmune demyelinating disorder of the central nervous system (CNS) which usually occurs with recurrent optic neuritis, transverse myelitis, acute disseminating
Transitioning from face-to-face to distance education. Part 1: A cross-sectional study in the former Yugoslavia during COVID-19
Description
CONCLUSION: Teachers used various old and new methods to provide learning opportunities despite COVID-19 constraints. Effective technology-based strategies are essential to ensure assessment integrity and enhance the learning environment.
Development of mRNA Nano-Vaccines for COVID-19 Prevention and its Biochemical Interactions with Various Disease Conditions and Age Groups
Description
This review has focused on the development of mRNA nano-vaccine and the biochemical interactions of anti-COVID-19 mRNA vaccines with various disease conditions and age groups. It studied five major groups of individuals with different disease
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial
Description
This study examined the role that cytokines may have played in the beneficial outcomes found when outpatient individuals infected with SARS-CoV-2 were transfused with COVID-19 convalescent plasma (CCP) early in their infection. We found that the pro
Suicide Attempts in an Italian Population with Cannabis Use Disorders: Results of a Follow-Up Study
Description
The relationship between cannabis use and suicidal behavior is complex, with no consensus in the literature. We used electronic health records of national health services to identify individuals who received a diagnosis of Cannabis Use Disorder in
High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients
Description
The presence of free severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid-antigen in sera (N-antigenemia) has been shown in COVID-19 patients. However, the link between the quantitative levels of N-antigenemia and COVID-19
Acceptance-Commitment Therapy for Women with Episodic Migraine: A Pilot Randomized Trial
Description
Objective: The aim of this study was to conduct a pilot, randomized controlled trial (RCT) of acceptance-commitment therapy (ACT) among women with episodic migraine, aged 18-65 years, and living in the United States. Background: Biobehavioral
Mortality in patients with COVID-19 and acute kidney injury on hemodialysis
Description
CONCLUSIONS: In this study it was documented a high proportion of deaths in patients with COVID-19 who developed acute kidney injury and required renal replacement therapy, which coincides with similar studies reported internationally.
COVID-19 vaccination in adults living with HIV
Description
The Centers for Disease Control and Prevention has recommended use of vaccines manufactured by Pfizer-BioNTech, Moderna, and Johnson & Johnson/Janssen to prevent COVID-19 infection in the United States. Although these vaccines are safe and have been
